优化头颈癌治疗方法：局部晚期疾病多学科治疗的优势与不足 - Suppr

Suppr

超能文献

Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advanced disease.

作者信息

Giralt J, Benavente S, Arguis M

机构信息

Radiation Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.

出版信息

Ann Oncol. 2008 Sep;19 Suppl 7:vii195-9. doi: 10.1093/annonc/mdn447.

DOI:10.1093/annonc/mdn447

PMID:18790948

Abstract

摘要

相似文献

Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advanced disease.优化头颈癌治疗方法：局部晚期疾病多学科治疗的优势与不足

Ann Oncol. 2008 Sep;19 Suppl 7:vii195-9. doi: 10.1093/annonc/mdn447.

Squamous cell carcinoma of the head and neck: past progress and future promise.头颈部鳞状细胞癌：过去的进展与未来的前景

CA Cancer J Clin. 1998 Jul-Aug;48(4):195-8. doi: 10.3322/canjclin.48.4.195.

Case report: Down-staging locally advanced head and neck cancer in an HIV infected patient in a limited resource setting.病例报告：在资源有限的环境中，一名感染艾滋病毒的患者局部晚期头颈癌的降期治疗

Malawi Med J. 2013 Jun;25(2):53-5.

[Development, current status and perspectives of tumor therapy in oromandibulofacial surgery--a determination of the current status].口腔颌面外科肿瘤治疗的发展、现状与展望——现状剖析

Fortschr Kiefer Gesichtschir. 1994;39:5-12.

Treatment of the neck in head and neck mucosal squamous cell carcinoma: what our experience teaches.头颈部黏膜鳞状细胞癌的颈部治疗：我们的经验教训

Front Radiat Ther Oncol. 1994;28:51-65. doi: 10.1159/000423373.

Head and neck cancer: state of the art.头颈癌：最新进展

J Med Liban. 1994;42(4):216-20.

Squamous cell carcinomas of the head and neck.头颈部鳞状细胞癌

BMJ. 2002 Oct 12;325(7368):822-7. doi: 10.1136/bmj.325.7368.822.

Outcome of locally advanced stage III and IV head and neck cancer treated by surgery and postoperative external beam radiotherapy.接受手术及术后体外照射放疗的局部晚期III期和IV期头颈癌的治疗结果。

Laryngoscope. 1987 May;97(5):615-20. doi: 10.1288/00005537-198705000-00016.

Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.肿瘤专家委员会建议对局部晚期头颈癌治疗结果的影响。

Oncology. 2008;75(3-4):186-91. doi: 10.1159/000163058. Epub 2008 Oct 8.

Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.颈部淋巴管与头颈部鳞状细胞癌：生物学意义及治疗考量

Surg Oncol Clin N Am. 1996 Jan;5(1):65-77.

引用本文的文献

Comparison of clinical nasal endoscopy, optical biopsy, and artificial intelligence in early diagnosis and treatment planning in laryngeal cancer: a prospective observational study.临床鼻内镜检查、光学活检与人工智能在喉癌早期诊断及治疗规划中的比较：一项前瞻性观察研究。

Front Oncol. 2025 Jun 10;15:1582011. doi: 10.3389/fonc.2025.1582011. eCollection 2025.

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer.重塑肿瘤微环境以克服人乳头瘤病毒阴性头颈癌的治疗耐药性。

Cancer Drug Resist. 2023 May 30;6(2):291-313. doi: 10.20517/cdr.2022.141. eCollection 2023.

Diagnostic Value of MRI Combined with CXCR4 Expression Level in Lymph Node Metastasis Head and Neck Squamous Cell Carcinoma.MRI 联合 CXCR4 表达水平对头颈部鳞癌淋巴结转移的诊断价值。

Comput Math Methods Med. 2022 Mar 8;2022:4073918. doi: 10.1155/2022/4073918. eCollection 2022.

The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer.多学科方法对头颈部癌（化疗）放疗患者的益处。

Curr Treat Options Oncol. 2016 Oct;17(10):53. doi: 10.1007/s11864-016-0431-3.

Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent.增强型水疱性口炎病毒（VSVΔ51）靶向头颈部肿瘤联合放射治疗或 ZD6126 血管破坏剂。

Cancer Cell Int. 2012 Jun 15;12(1):27. doi: 10.1186/1475-2867-12-27.

A prospective study of the clinical impact of a multidisciplinary head and neck tumor board.多学科头颈部肿瘤委员会的临床影响的前瞻性研究。

Otolaryngol Head Neck Surg. 2010 Nov;143(5):650-4. doi: 10.1016/j.otohns.2010.07.020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验